The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression

Autor: Marisa Blanquet, Curzio Rüegg, Lionel Ponsonnet, Jelena Zaric, Gerhard Christofori, Qiang Lan, Yu-Ting Huang
Jazyk: angličtina
Rok vydání: 2015
Předmět:
0301 basic medicine
medicine.medical_specialty
Angiogenesis
Blotting
Western

Mice
Transgenic

Biology
Neuroendocrine tumors
insulinoma
medicine.disease_cause
03 medical and health sciences
angiogenesis
Islets of Langerhans
Internal medicine
Cell Line
Tumor

medicine
Animals
Insulinoma
geography
geography.geographical_feature_category
Integrin alpha6beta1
Neovascularization
Pathologic

Reverse Transcriptase Polymerase Chain Reaction
Pancreatic islets
Matricellular protein
CYR61
GTPase-Activating Proteins
Antibodies
Monoclonal

medicine.disease
Islet
invasion
Vascular Endothelial Growth Factor Receptor-2
Mice
Inbred C57BL

Pancreatic Neoplasms
Neuroendocrine Tumors
030104 developmental biology
Endocrinology
medicine.anatomical_structure
Cell Transformation
Neoplastic

Oncology
transgenic model
Cancer research
Disease Progression
Carcinogenesis
Research Paper
Cysteine-Rich Protein 61
Zdroj: Oncotarget
ISSN: 1949-2553
Popis: The significance of matricellular proteins during development and cancer progression is widely recognized. However, how these proteins actively contribute to physiological development and pathological cancer progression is only partially elucidated. In this study, we investigated the role of the matricellular protein Cysteine-rich 61 (CYR61) in pancreatic islet development and carcinogenesis. Transgenic expression of CYR61 in β cells (Rip1CYR mice) caused irregular islets morphology and distorted sorting of α cells, but did not alter islets size, number or vascularization. To investigate the function of CYR61 during carcinogenesis, we crossed Rip1CYR mice with Rip1Tag2 mice, a well-established model of β cell carcinogenesis. Beta tumors in Rip1Tag2CYR mice were larger, more invasive and more vascularized compared to tumors in Rip1Tag2 mice. The effect of CYR61 on angiogenesis was fully abrogated by treating mice with the anti-VEGFR2 mAb DC101. Results from in vitro assays demonstrated that CYR61 modulated integrin α₆β₁-dependent invasion and adhesion without altering its expression. Taken together, these results show that CYR61 expression in pancreatic β cells interferes with normal islet architecture, promotes islet tumor growth, invasion and VEGF/VERGFR-2-dependent tumor angiogenesis. Taken together, these observations demonstrate that CYR61 acts as a tumor-promoting gene in pancreatic neuroendocrine tumors.
Databáze: OpenAIRE